期刊文献+

姜黄素衍生物FM02的溶解度、抗抑郁和抗炎作用 被引量:3

The Anti-Depression Effect and the Anti-Inflammation Effect of Curcumin Derivative FM02
下载PDF
导出
摘要 目的测定姜黄素衍生物FM02的溶解度及药理作用。方法分别用水、二甲亚砜(DMSO)、甲醇溶解FM02,测定溶解度;用强迫小鼠游泳实验测定抗抑郁作用;用巴豆油引起小鼠耳肿胀模型测定抗炎作用;用MTT法测定对K562细胞增殖作用的影响。结果FM02易溶于水、甲醇及DMSO,溶解度均>0.1 g/g;剂量5mg/kg与10 mg/kg灌胃对小鼠强迫游泳模型有明显的抗抑郁作用,5 mg/kg相对抗抑郁强度为46.8%;一次性给药对巴豆油引起小鼠耳肿胀模型有一定的抑制作用,但与阴性对照组比较,差异不显著;对K562细胞无抑制作用。结论FM02具有较好的水溶性,剂量5 mg/kg与10 mg/kg小鼠灌胃具有较好的抗抑郁作用。 Objective To determinate the solubility and pharmacological activity of curcumin derivative FM02. Methods Solubility assay of FM02 was tested with water, dimethyl sulfoxide(DMSO), and carbinol. Anti-depression effect of FM02 was determined with forced swimming method. Anti-inflammatory effect of FM02 was tested with croton oil induced mouse ear edema model. To determine the inhibition effect of the proliferation of K562 cell was detrmined. Results FM02 was water soluble. The solubility in carbinol or DMSO was less than 0.1 g/g. The anti-depression effect of FM02 was significant at dosage of 5 mg/kg and 10 mg/kg ig and achieved 46.8% tensity. FM02 showed some anti-inflammatory effect. FM02 didn't inhibit the growth of cell line K562. Conclusion FM02 is water soluble. The anti-depression effect of FM02 is significant at dosage of 5 mg/kg and 10 mg/kg ig.
出处 《福建医科大学学报》 2006年第4期341-343,共3页 Journal of Fujian Medical University
基金 福建省自然科学基金资助项目(C992001)
关键词 姜黄素 K562细胞 抗抑郁药 免疫酶技术 药物设计 小鼠 curcumin K562 cells antidepressive agents immunoenzyme techniques drug design mice
  • 相关文献

参考文献5

  • 1许实波,唐孝礼.姜黄素的药理作用研究概况[J].中草药,1991,22(3):140-141. 被引量:53
  • 2王旗,王夔.姜黄素的代谢研究[J].中国药理学通报,2003,19(10):1097-1101. 被引量:49
  • 3沃格尔 HG,沃格尔 WH. 大鼠游泳绝望实验、巴豆油引起大鼠和小鼠耳肿胀模型[M]//药理学实验指南—新药发现和药理学评价. 北京:科学出版社, 2001:402,535.
  • 4司徒镇强 吴军正.细胞培养[M].西安:世界图书版出版公司,2004.78-202.
  • 5库宝善,徐英. 姜黄素及其衍生物用于制备治疗抑郁症药物的应用:中国,1568944A[P]. 2005-0126.

二级参考文献22

  • 1Wang YJ, Pan MH, Cheng AL et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharmaceu & Biomed Analysis, 1997 ; 15 (12) : 1867-76.
  • 2Oetari S, Sudibyo M, Commandeur Jan NM et al, Effects of curcumin on cytochrome p450 and glutathione S-transferase activities in rat liver. Biochem Pharmacol, 1996,51(1) : 39-45.
  • 3Wahlstrom B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol, 1978;43(2) :86-92.
  • 4Holder GM, Plummer JL, Ryan AJ. The metabolism and excretion of curcumin ( 1,7-his-( 4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica, 1978;8(12):761-8.
  • 5Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Tozicology, 1980;16 (3): 25965.
  • 6Ravindranath V, Chandrasekhara N. Metabolism of curcuminstudies with [^3 H]curcumin. Toxicology, 1982; 22 : 337 - 44.
  • 7Ravindranath V, Chandrasekhara N. In Vitro studies on the intestinal absorption of curcumin in rats. Toxicology, 1981;20(2-3): 251-7.
  • 8Shoba G, Joy D, Joseph T et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.Planta Medica , 1998;64:353-6.
  • 9Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabolitism & Disposition, 1999;27(4) :486-94.
  • 10Asai A, Miyazawa T. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sciences, 2000;67:2785-93.

共引文献381

同被引文献53

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部